Treatment of Cervical Spinal Cord Injury With Imatinib - a Safety and Feasibility Study

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
This is a phase II, single center, open-label, non randomized clinical study to assess the uptake, safety and tolerability of Imatinib in acute Cervical Spinal Cord Injury patients. The aim is to determine if Imatinib reaches sufficient blood levels when given to patients with cervical spinal cord injury, via a gastric feeding tube, and also evaluate the safety and tolerability of this drug treatment.
Epistemonikos ID: ebf4d4134906998c1472ee8f6255eaff602e73d3
First added on: May 12, 2024